Cargando…
The Role of IL-35 in the Pathophysiological Processes of Liver Disease
It is known that liver diseases have several characteristics of massive lipid accumulation and lipid metabolic disorder, and are divided into liver inflammation, liver fibrosis, liver cirrhosis (LC), and hepatocellular carcinoma (HCC) in patients. Interleukin (IL)-35, a new-discovered cytokine, can...
Autores principales: | Hu, Shuang, Lian, Pan-pan, Hu, Ying, Zhu, Xing-yu, Jiang, Shao-wei, Ma, Qiang, Li, Liang-yun, Yang, Jun-fa, Yang, Li, Guo, Hai-yue, Zhou, Hong, Yang, Chen-chen, Meng, Xiao-ming, Li, Jun, Li, Hai-wen, Xu, Tao, Zhou, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873894/ https://www.ncbi.nlm.nih.gov/pubmed/33584256 http://dx.doi.org/10.3389/fphar.2020.569575 |
Ejemplares similares
-
The Role of IL-36 in the Pathophysiological Processes of Autoimmune Diseases
por: Chen, Wen-jian, et al.
Publicado: (2021) -
The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19
por: Li, Peng, et al.
Publicado: (2021) -
Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists
por: Dong, Fa-Wu, et al.
Publicado: (2018) -
DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis
por: Pan, Xue-yin, et al.
Publicado: (2018) -
GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
por: Otkur, Wuxiyar, et al.
Publicado: (2023)